Clinical Trial Update: Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness [Phase 2]

View source ↗

Summary

Phase 2 trial update on THN102 for Parkinson's disease with excessive daytime sleepiness; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• THN102

Snippet

Sponsor: Theranexus | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-12-01